• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压合并亚临床血管损伤患者血浆醛固酮水平与动脉僵硬度参数之间的关系

Relationship between plasma aldosterone levels and arterial stiffness parameters in hypertensive patients with subclinical vascular damage.

作者信息

Petramala L, Concistrè A, Mezzadri M, Sarlo F, Circosta F, Schina M, Soldini M, Iannucci G, Letizia C

机构信息

Department of Translational and Precision Medicine, "Sapienza" University of Rome, Rome, Italy.

University Cattolica "Sacro Cuore", Rome, Italy.

出版信息

Int J Cardiol Cardiovasc Risk Prev. 2022 Jun 6;14:200138. doi: 10.1016/j.ijcrp.2022.200138. eCollection 2022 Sep.

DOI:10.1016/j.ijcrp.2022.200138
PMID:36060288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9434407/
Abstract

PURPOSE

Aldosterone plays important role in cardiovascular damage. Aim was to evaluate arterial subclinical damage through arterial stiffness parameters in patients with Essential Hypertension (EH) and Primary Aldosteronism (PA).

METHODS

From 2018 to 2019 we consecutively enrolled 82 subjects (37 males and 45 women), distinguished in two groups: 60 EH [systolic blood pressure (SBP) 143.4 ± 16.7 mmHg, diastolic blood pressure (DBP) 89.5 ± 12.1 mmHg] and 22 PA (SBP 149 ± 19.5 mmHg, DBP 92.7 ± 12.4 mmHg) [5 with aldosterone-secreting adrenal adenoma(APA), 17 with idiopathic aldosteronism(IHA)]; 40 matched normotensive subjects (NS) were enrolled (SBP 109.7 ± 6.2 mmHg, DBP 71.3 ± 9.7 mmHg). We used non-invasive applanation tonometer to acquire pressure waveform.

RESULTS

PA patients showed higher μ-Albuminuria (UAE) (65.7 ± 11.0mg/24 h) than EH and NS (21.5 ± 7.0 mg/24 h and 21.5 ± 7.0 mg/24 h, respectively); APA group showed increased levels of arterial stiffness index (11.7 ± 4.8 m/s; p < 0.02) compared to EH subjects (8.3 ± 3 m/s) and NS subjects (7.2 ± 1.7 m/s) as well as higher carotid intima-media thickness (c-IMT); APA patients showed significant reduction of subendocardial viability ratio (SEVR) and travel time of the reflected waves (TI) respect EH and NS. PA groups showed high percentage of augmented "worsening age" (60%), compared to EH (38%) and NS (37%). PAC was positively correlated with Arterial Stiffness Index. Performing multiple linear regression analysis (evaluating anthropometric and biochemical parameters), we found UAE as predictor of Augmentation Index, Arterial Stiffness Index and Travel Time of reflected waves in the enrolled population.

CONCLUSION

PA patients showed higher cardiovascular subclinical damage respect to EH; UAE excretion had significant correlation with aldosterone, resulting best marker of subclinical vascular remodeling.

摘要

目的

醛固酮在心血管损伤中起重要作用。本研究旨在通过动脉僵硬度参数评估原发性高血压(EH)和原发性醛固酮增多症(PA)患者的动脉亚临床损伤情况。

方法

2018年至2019年,我们连续纳入了82名受试者(37名男性和45名女性),分为两组:60名EH患者[收缩压(SBP)143.4±16.7mmHg,舒张压(DBP)89.5±12.1mmHg]和22名PA患者(SBP 149±19.5mmHg,DBP 92.7±12.4mmHg)[5例为醛固酮分泌性腺瘤(APA),17例为特发性醛固酮增多症(IHA)];同时纳入40名匹配的血压正常受试者(NS)(SBP 109.7±6.2mmHg,DBP 71.3±9.7mmHg)。我们使用无创压平眼压计获取压力波形。

结果

PA患者的微量白蛋白尿(UAE)水平(65.7±11.0mg/24h)高于EH患者和NS受试者(分别为21.5±7.0mg/24h和21.5±7.0mg/24h);与EH受试者(8.3±3m/s)和NS受试者(7.2±1.7m/s)相比,APA组的动脉僵硬度指数水平升高(11.7±4.8m/s;p<0.02),颈动脉内膜中层厚度(c-IMT)也更高;与EH患者和NS受试者相比,APA患者的心内膜下存活比(SEVR)和反射波传播时间(TI)显著降低。与EH患者(38%)和NS受试者(37%)相比,PA组中“年龄恶化”增加的比例较高(60%)。血浆醛固酮浓度(PAC)与动脉僵硬度指数呈正相关。进行多元线性回归分析(评估人体测量和生化参数)时,我们发现UAE是所纳入人群中增强指数、动脉僵硬度指数和反射波传播时间的预测指标。

结论

与EH患者相比,PA患者的心血管亚临床损伤更严重;UAE排泄与醛固酮显著相关,是亚临床血管重塑的最佳标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc1/9434407/5b540bf367e6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc1/9434407/aeaf5a021c44/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc1/9434407/5b540bf367e6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc1/9434407/aeaf5a021c44/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cc1/9434407/5b540bf367e6/gr2.jpg

相似文献

1
Relationship between plasma aldosterone levels and arterial stiffness parameters in hypertensive patients with subclinical vascular damage.高血压合并亚临床血管损伤患者血浆醛固酮水平与动脉僵硬度参数之间的关系
Int J Cardiol Cardiovasc Risk Prev. 2022 Jun 6;14:200138. doi: 10.1016/j.ijcrp.2022.200138. eCollection 2022 Sep.
2
Evaluation of Intra-Renal Stiffness in Patients with Primary Aldosteronism.原发性醛固酮增多症患者肾内僵硬度的评估。
High Blood Press Cardiovasc Prev. 2022 Jan;29(1):49-56. doi: 10.1007/s40292-021-00485-3. Epub 2021 Nov 10.
3
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.醛固酮腺瘤患者的肾上腺切除术可改善颈动脉内膜中层厚度增加和动脉僵硬度。
Atherosclerosis. 2012 Mar;221(1):154-9. doi: 10.1016/j.atherosclerosis.2011.12.003. Epub 2011 Dec 8.
4
Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension.与原发性高血压相比,原发性醛固酮增多症患者动脉壁僵硬度增加。
Am J Hypertens. 2006 Sep;19(9):909-14. doi: 10.1016/j.amjhyper.2006.02.002.
5
Primary aldosteronism: Higher volume load, cardiac output and arterial stiffness than in essential hypertension.原醛症:比原发性高血压具有更高的容量负荷、心输出量和动脉僵硬度。
J Intern Med. 2021 Jan;289(1):29-41. doi: 10.1111/joim.13115. Epub 2020 Jun 29.
6
Have main types of primary aldosteronism different phenotype?原发性醛固酮增多症的主要类型有不同的表型吗?
Physiol Res. 2012;61(4):431-6. doi: 10.33549/physiolres.932335. Epub 2012 Jun 6.
7
Atherosclerotic Burden and Arterial Stiffness are Not Increased in Patients with Milder Forms of Primary Aldosteronism Compared to Patients with Essential Hypertension.与原发性高血压患者相比,轻度原发性醛固酮增多症患者的动脉粥样硬化负担和动脉僵硬度没有增加。
Horm Metab Res. 2021 Mar;53(3):178-184. doi: 10.1055/a-1326-2164. Epub 2021 Jan 13.
8
Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.原发性醛固酮增多症患者的日间血压模式与心脏损害。
Endocrine. 2021 Jun;72(3):835-843. doi: 10.1007/s12020-021-02606-3. Epub 2021 Jan 21.
9
Unveiling the Silent Danger of Childhood Obesity: Non-Invasive Biomarkers Such as Carotid Intima-Media Thickness, Arterial Stiffness Surrogate Markers, and Blood Pressure Are Useful in Detecting Early Vascular Alterations in Obese Children.揭示儿童肥胖的潜在危害:诸如颈动脉内膜中层厚度、动脉僵硬度替代标志物和血压等非侵入性生物标志物有助于检测肥胖儿童早期血管改变。
Biomedicines. 2023 Jun 26;11(7):1841. doi: 10.3390/biomedicines11071841.
10
The association of plasma sortilin with essential hypertension and subclinical carotid atherosclerosis: A cross-sectional study.血浆sortilin与原发性高血压及亚临床颈动脉粥样硬化的关联:一项横断面研究。
Front Cardiovasc Med. 2022 Oct 12;9:966890. doi: 10.3389/fcvm.2022.966890. eCollection 2022.

引用本文的文献

1
Effect of spironolactone on cardiovascular and renal outcomes in patients with chronic kidney disease.螺内酯对慢性肾脏病患者心血管及肾脏结局的影响。
Clin Kidney J. 2025 Aug 6;18(9):sfaf247. doi: 10.1093/ckj/sfaf247. eCollection 2025 Sep.
2
Response to the Letter to the Editor: Rare Endocrine Disorders and Peripheral Arterial Disease.对编辑来信的回复:罕见内分泌疾病与外周动脉疾病
Curr Vasc Pharmacol. 2025;23(1):9-11. doi: 10.2174/0115701611372375241125111238.
3
Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?

本文引用的文献

1
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.2020年意大利动脉高血压学会(SIIA)原发性醛固酮增多症管理实用指南。
Int J Cardiol Hypertens. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029. eCollection 2020 Jun.
2
Renal damage in primary aldosteronism: a systematic review and meta-analysis.原发性醛固酮增多症中的肾损伤:系统评价和荟萃分析。
J Hypertens. 2020 Jan;38(1):3-12. doi: 10.1097/HJH.0000000000002216.
3
Aldosterone Induces Vascular Damage.醛固酮诱导血管损伤。
肥胖、醛固酮过多与盐皮质激素受体激活:平行还是交叉情况?
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1384-1390. doi: 10.1111/jch.14898. Epub 2024 Nov 25.
4
Research Progress and Clinical Value of Subendocardial Viability Ratio.心内膜下存活心肌比的研究进展及临床价值。
J Am Heart Assoc. 2024 Mar 19;13(6):e032614. doi: 10.1161/JAHA.123.032614. Epub 2024 Mar 12.
5
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review.原发性醛固酮增多症相关心血管并发症研究的最新进展:简要综述
Hypertens Res. 2024 May;47(5):1103-1119. doi: 10.1038/s41440-023-01538-x. Epub 2024 Jan 16.
6
Central diastolic blood pressure, plasma aldosterone and uric acid are associated with microalbuminuria in essential hypertension: a case-control study.原发性高血压患者中心舒张压、血浆醛固酮和尿酸与微量白蛋白尿相关:一项病例对照研究。
BMC Cardiovasc Disord. 2023 Oct 17;23(1):511. doi: 10.1186/s12872-023-03515-1.
Hypertension. 2019 Sep;74(3):623-629. doi: 10.1161/HYPERTENSIONAHA.118.12342. Epub 2019 Jul 29.
4
Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries.醛固酮与盐皮质激素受体在心血管系统调节以及心脏和动脉病理重塑中的作用
J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.01. Epub 2019 Mar 18.
5
Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.依普利酮改善特发性醛固酮增多症患者的血管内皮功能和动脉僵硬度并抑制 Rho 相关激酶活性:一项初步研究。
J Hypertens. 2019 May;37(5):1083-1095. doi: 10.1097/HJH.0000000000001989.
6
Arterial stiffness evaluated by pulse wave velocity is not predictive of the improvement in hypertension after adrenal surgery for primary aldosteronism: A multicentre study from the French European Society of Hypertension Excellence Centres.动脉僵硬度评估的脉搏波速度不能预测原发性醛固酮增多症肾上腺手术后高血压的改善:来自法国高血压卓越中心欧洲高血压学会的多中心研究。
Arch Cardiovasc Dis. 2018 Oct;111(10):564-572. doi: 10.1016/j.acvd.2018.01.004. Epub 2018 Mar 16.
7
Aldosterone as a mediator of microvascular and macrovascular damage in a population of normotensive to early-stage hypertensive individuals.醛固酮作为正常血压至早期高血压个体群体中微血管和大血管损伤的介质。
J Am Soc Hypertens. 2018 Jan;12(1):50-57. doi: 10.1016/j.jash.2017.12.001. Epub 2017 Dec 11.
8
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.肾上腺偶发瘤的管理:欧洲内分泌学会临床实践指南与欧洲肾上腺肿瘤研究网络合作制定
Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467.
9
Enhanced Soluble Serum CD40L and Serum P-Selectin Levels in Primary Aldosteronism.原发性醛固酮增多症患者血清可溶性CD40L和血清P-选择素水平升高
Horm Metab Res. 2016 Jul;48(7):440-5. doi: 10.1055/s-0042-103588. Epub 2016 Apr 21.
10
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.原发性醛固酮增多症的管理:病例检出、诊断和治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2016 May;101(5):1889-916. doi: 10.1210/jc.2015-4061. Epub 2016 Mar 2.